Stock AUSPEX PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Auspex Pharmaceuticals Inc Stock

Equities

US05211J1025

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Auspex Pharmaceuticals Inc
2015 Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions RE
2015 Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal RE

Latest news about Auspex Pharmaceuticals Inc

Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions RE
Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal RE
Stocks rally on merger activity; dollar gains RE
Stocks rally on merger activity; dollar gains RE
FUJIFILM : Wall St. rebounds from recent losses; deals help RE
Auspex Pharmaceuticals : Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion RE
More news

Press releases Auspex Pharmaceuticals Inc

Auspex Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Auspex Pharmaceuticals, Inc. PR
Auspex Pharmaceuticals : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Auspex Pharmaceuticals, Inc. Stockholders BU
Auspex Pharmaceuticals : Pharma Stockholders Encouraged to Contact Securities Law Firm about Takeover PR
Results of Auspex Pharmaceuticals' Phase 3 Registration Trial of SD-809 to be Presented at AAN Annual Meeting GL
Auspex Pharmaceuticals Reports Fourth Quarter 2014 Results and Business Highlights GL
More press releases

News in other languages on Auspex Pharmaceuticals Inc

Wall Street rebondit avec les fusions-acquisitions
FUJIFILM : Wall Street ouvre en hausse avec les fusions-acquisitions
Auspex Pharmaceuticals : Teva rachète l'américain Auspex pour 3,5 milliards de dollars
Adamis Pharmaceuticals : Les valeurs à suivre sur les marchés américains
More news

Managers and Directors - Auspex Pharmaceuticals Inc

Managers TitleAgeSince
Brendan O'Grady CEO
 Chief Executive Officer 57 -
Members of the board TitleAgeSince
Rod A. Ferguson BRD
 Director/Board Member 67 12-12-31
Alex Zisson BRD
 Director/Board Member 54 13-10-16
Sep Sarshar FOU
 Founder 57 01-02-27
More insiders

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.26% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.41% 95.71B
ARGENX SE Stock argenx SE
+0.93% 22.02B
BIONTECH SE Stock BioNTech SE
-17.84% 20.9B
GENMAB A/S Stock Genmab A/S
-9.23% 17.85B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.83% 16.21B
BEIGENE, LTD. Stock BeiGene, Ltd.
-17.63% 15.52B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+4.55% 13.86B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+32.11% 12.04B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock